Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | stella

Back to Intrahepatic Cholangiocarcinoma (Icc) trials

Recruiting

Plain-English translation of NCT07640048 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Trial locations(1 site)

China

Peking Union Medical College Hospital (PUMCH), Beijing

Key details

Sponsor

Peking Union Medical College Hospital

Enrollment target

~90 participants

Started

May 2025

Primary completion

December 2028

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Baoluhe Zhang

Peking Union Medical College Hospital (PUMCH)

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.